• XPO1 Inhibition by Eltanexor Reduces Colorectal Tumorigenesi

  2026-05-20

  This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, effectively reduces colorectal cancer development by modulating the Wnt/β-catenin signaling pathway and suppressing COX-2 expression. The findings provide a mechanistic rationale for targeting nuclear export in chemopreventive strategies for colorectal and potentially other XPO1-driven cancers.

• ER Stress Suppression Restores Pulmonary Function in CVA via

  2026-05-19

  This study reveals that Suhuang antitussive capsule protects against pulmonary dysfunction in cough variant asthma (CVA) by inhibiting endoplasmic reticulum (ER) stress, thereby suppressing NLRP3 inflammasome activation. The findings underscore the central role of the RIP1-RIP3-DRP1 axis in linking ER stress to inflammasome-driven inflammation, providing new mechanistic insight for therapeutic intervention in CVA.

• 2-APB: Empowering Mechanistic & Translational Calcium Resear

  2026-05-19

  Explore how 2-APB (2-aminoethoxydiphenyl borate) transforms the landscape of calcium signaling research, bridging mechanistic insights with actionable strategies for translational scientists. Drawing on recent advances in autophagy-apoptosis modeling and oxidative stress, this thought-leadership article integrates cutting-edge experimental evidence, workflow best practices, and a critical appraisal of the compound’s role in driving innovation beyond standard product narratives.

• Doxycycline: Tetracycline Antibiotic and Metalloproteinase I

  2026-05-18

  Doxycycline is a tetracycline antibiotic with broad-spectrum activity and potent metalloproteinase inhibition. It demonstrates antiproliferative effects against cancer cells and is widely used in research for its dual antimicrobial and anticancer properties.

• 0.4% Trypan Blue Solution: Technical Guidance for Cell Viabi

  2026-05-18

  0.4% Trypan Blue Solution enables practical, membrane-integrity–based cell viability measurement for cell culture and cytotoxicity assays. It is not suitable for diagnostic or clinical applications, and its use should be limited to research workflows requiring rapid discrimination of live and dead cells.

• GST Inhibition Reveals Mechanisms of Insecticide Resistance

  2026-05-17

  This study demonstrates that glutathione S-transferase (GST) activity is central to Megalurothrips usitatus resistance against lambda-cyhalothrin, a widely used pyrethroid insecticide. By inhibiting GST with diethyl maleate, the researchers showed a marked reduction in antioxidant defenses and a dramatic increase in insecticide sensitivity, offering mechanistic insight into redox regulation and resistance management.

• Tin Mesoporphyrin IX: Strategic Inhibition of Heme Oxygenase

  2026-05-16

  This thought-leadership article explores Tin Mesoporphyrin IX (chloride) as a precision tool for translational researchers investigating heme oxygenase biology in metabolic, inflammatory, and emerging antiviral contexts. By blending mechanistic depth, protocol recommendations, and strategic outlook, it highlights both the opportunities and limitations of deploying this potent heme oxygenase inhibitor in cutting-edge biomedical workflows.

• Neurotensin (CAS 39379-15-2): Advanced Insights into GPCR Tr

  2026-05-15

  Explore the sophisticated role of Neurotensin as a Neurotensin receptor 1 activator in dissecting GPCR trafficking and miRNA regulation. This article uniquely bridges mechanistic understanding with evidence-based assay guidance.

• Scalable Bioreactor Production of iMSC-Derived EVs for Thera

  2026-05-15

  Gong et al. (2025) present a robust, scalable biomanufacturing system for producing extracellular vesicles (EVs) from induced mesenchymal stem cells (iMSCs) derived from extended pluripotent stem cells (EPSCs). Their platform addresses key bottlenecks in EV therapy—namely donor variability, scalability, and product consistency—offering practical advances for regenerative medicine and translational research.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-05-14

  The referenced study uncovers a novel function for the transcription factor HOXC8 in non-small cell lung carcinoma (NSCLC): by recruiting HDAC1/2 to the CASP1 promoter, HOXC8 represses caspase-1 expression, thereby preventing pyroptotic cell death. This mechanistic insight enhances understanding of tumor cell survival and suggests new targets for modulating inflammatory cell death in cancer.

• Glycogen Colorimetric Assay Kit II: Unveiling Glycogen Dynam

  2026-05-14

  Explore how the Glycogen Colorimetric Assay Kit II enables high-precision, interference-resistant quantification of glycogen, with a focus on optimizing endurance training research. This article reveals advanced assay considerations and scientific context not found elsewhere.

• NU6300 Blocks Gasdermin D Pyroptosis via Cysteine-191 Target

  2026-05-13

  Jiang et al. identify NU6300 as a covalent inhibitor of gasdermin D, revealing a new mechanism that impedes both cleavage and palmitoylation at cysteine-191. These findings advance our understanding of inflammasome-driven pyroptosis and highlight NU6300 as a promising candidate for inflammatory disease intervention.

• CIH-Induced Apoptosis: Microbiome-Metabolite Axis and Mdivi-

  2026-05-13

  This study uncovers how chronic intermittent hypoxia (CIH) provokes pulmonary apoptosis through gut microbiota and metabolite dysregulation, and demonstrates that the selective DRP1 inhibitor Mdivi-1 can reverse these effects. The findings offer new mechanistic insight into the gut-mitochondrial axis in obstructive sleep apnea and highlight Mdivi-1 as a powerful tool for mitochondrial dynamics research.

• Ambroxol Modulation of Nav1.8, TRPV1, and TRPA1 in Neuropath

  2026-05-12

  This study elucidates the molecular targets of ambroxol in sensory neurons relevant to topical neuropathic pain treatment, revealing species-specific inhibition of Nav1.8 and modulatory effects on human TRPV1 and TRPA1 channels. These findings clarify ambroxol’s potential mechanisms and offer a foundation for optimizing topical analgesic strategies.

• Bovine Liver Organoid Model Advances Fatty Liver Disease Res

  2026-05-12

  Lei et al. establish a robust bovine liver organoid model to recapitulate fatty liver disease seen in high-yielding dairy cows. This system enables precise study of disease mechanisms and therapeutic screening, addressing a major gap in livestock metabolic disease research with potential for reducing animal usage.

15326 records 1/1022 page Next 12345 下5页 Last page